Good MorningEquity markets advanced on Wednesday, setting a new three months ahead of the Thanksgiving Holiday. The move is partly due to a gain in Microsoft driven by the reinstatement of Sam Altman to the held of OpenAI. Shares of Microsoft moved up to set a new all-time high on the news and could head higher. The company is establishing itself as a rival to AI powerhouse NVIDIA and will likely build on the momentum gained in 2023.
The S&P 500 closed with a gain near 0.5%, but the move wasn't strong. The index tests resistance at a critical level and has difficulty advancing above it. If the market doesn't commit soon, bearish traders could come back to the market. In this scenario, the index is capped at critical levels and below the all-time high, where it is likely to remain range-bound. With the holiday shopping season looking like a bust, it's unlikely the S&P 500 will set new highs soon without a change to the fundamentals. That won't come without a change in the FOMC policy stance, which isn't likely until next year. Featured: The A.I. Trend Has These 7 Stocks Set To Soar (Darwin) 
|
Stocks | | |
In the past month, consumer discretionary stocks have been on a tear, with the Consumer Discretionary Select Sector SPDR Fund (NYSEARCA: XLY) returning 10.47%. That led all sectors except technology stocks during that time.
In the past month, the SPDR S&P 500 ETF Trust (NYSEARCA: SPY) r... Read the Full Story |
|
From Our PartnersRumors are circulating of a new currency that will be backed by gold. A huge story, if true. And while it’s impossible to know how it will pan out, there’s one important move you should make right now, before this happens. It’s the best way to protect your wealth today. Because if you’re not careful, YOU could be the one who pays the price | | | | Check out this important warning right here. |
|
Stocks | | |
The financial sector, particularly bank stocks, has been on a tear lightly, clawing back losses from the year and edging into positive territory. So far during the quarter, the financial sector has proven to be an outperforming sector.
Bank stocks surged last week follow... Read the Full Story |
|
Markets | | |
Small-cap stocks are finally staging a comeback after underperforming against medium to large-cap stocks this year.
This year's notable trend has been the significant outperformance of large-cap stocks, specifically those in the technology sector, versus small-cap stocks. However, with the ... Read the Full Story |
|
From Our PartnersIf you’re looking for an INCREDIBLE deal on stocks with huge growth potential, now is the time to look at this list our team prepared.
(**By clicking the link you are subscribing to the Summa Money Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here)
| | Download The List With Details On Each Stock Here |
|
Markets | | |
Value is where you find it. Today, you can find it with Tower Semiconductor Ltd. (NASDAQ: TSEM), Johnson Controls International PLC (NYSE: JCI), Barnes Group Inc. (NYSE: B) and Howard Hughes Holdings Inc. (NYSE: HHH).
These companies trade at a significant discount ... Read the Full Story |
|
Markets | | |
Don't be surprised if you see many shoppers at The Gap Inc. (NYSE: GPS) this holiday season.
Why?
The retailer is crushing it.
Well, sort of.
On Friday, the company behind Old Navy, Banana Republic, Athleta and Gap stores reported third-quarter earnings pe... Read the Full Story |
|
From Our PartnersLithium Americas has handed investors profits of 2,705%.
Sigma Lithium has return an almost identical 2,706% since it began trading in 2018.
And Alkem Limited is up 174% over the last 5 years and 733% over the last 10 years.
Now's the time to invest in this lithium company, while it's a small cap around 25M. | | Learn More |
|
Stocks | | | Stocks drifted to a mixed finish Friday after a half-day trading session capped a holiday shortened week that left the major indexes with their fourth straight winning week. The S&P 500 inched up 0.1% after wavering between small gains and losses much of the day. The Dow Jones Industrial Average... Read the Full Story |
|
Markets | | | World shares were mixed on Thursday after a modest advance on Wall Street that kept the market on track for a fourth straight weekly gain. Markets in Japan and the U.S. are closed for holidays. Oil prices initially fell about $1 a barrel after OPEC postponed until next week a meeting to discuss prod... Read the Full Story |
|
Markets | | | Shares were mostly lower in Asia on Thursday after a modest advance on Wall Street that kept the market on track for a fourth straight weekly gain. Markets in Japan and the U.S. are closed Thursday for holidays. Oil prices fell about $1 a barrel after OPEC postponed until next week a meeting to disc... Read the Full Story |
|
Markets | | | The shelves at Moscow supermarkets are full of fruit and vegetables, cheese and meat. But many of the shoppers look at the selection with dismay as inflation makes their wallets feel empty. Russia's Central Bank has raised its key lending rate four times this year to try to get inflation under contr... Read the Full Story |
|
Markets | | | Turkey’s central bank delivered another huge interest rate hike on Thursday as it tries to curb double-digit inflation that has left households struggling to afford food and other basic goods.The bank pushed its policy rate up by 5 percentage points, to 40%, marking its sixth big interest rate hike ... Read the Full Story |
|
Friday's Early Bird Stock Of The Day Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. The company also focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer as an alternative to bacillus calmetteguérin therapy. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts. | | View Today's Stock Pick |
|
